Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07066566Recruiting
Comparing two ways to give high flow oxygen through the nose
This trial compares two types of high flow nasal cannula to see which one makes it easier for you to breathe. You may join if you are 18 or older and have normal oxygen levels without extra oxygen.
LarissaAges 18 years+ - NCT07067905RecruitingEarly Phase 1
PET scan test for glioblastoma and kidney cancer
This trial tests a new PET scan tracer called [68Ga]Ga-XT771 to see if it can better detect glioblastoma (a type of brain tumor) and clear cell renal cell carcinoma (a type of kidney cancer). If you have one of these cancers, this scan might help your doctor see the tumor more clearly.
BeijingAges 18 years+ - NCT07067983Recruiting
Gastric cancer screening study with the GRAPE model
This trial is testing a new model called GRAPE to see if it can help find gastric cancer earlier using routine CT scans. If you are between 18 and 80 and having a chest and abdomen CT, you might be able to join.
Hangzhou, ZhejiangAges 18–80 - NCT07068438Recruiting
Pulsed electric field for chronic bronchitis
This study tests a new treatment that uses brief electric pulses to clear blocked airways in people with chronic bronchitis. It might help if you have a long-term cough with mucus and standard medicines aren't enough.
Hefei, AnuiAges 35–80 - NCT07068607RecruitingPhase 4
Comparing two treatments for H. pylori infection
This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.
Xi'an, ShaanxiAges 18–70 - NCT07069647Recruiting
AI screening for diabetic eye disease and macular degeneration
This trial tests if an AI tool can help detect diabetic retinopathy and age-related macular degeneration in older adults visiting family medicine or geriatric clinics. It aims to catch these eye conditions early, before they cause vision loss.
TaipeiAges 20 years+ - NCT07070050RecruitingPhase 4
NSAIDs after laparoscopic surgery: continuous or bolus?
This study compares giving NSAID pain relievers continuously through an IV versus as single doses (bolus) after laparoscopic surgery to find which method provides better pain relief with fewer side effects.
Moscow, Moscow OblastAges 18 years+ - NCT07070323RecruitingPhase 1/Phase 2
Nanobody CD5-CAR T cells for T-cell cancers
This trial tests a new treatment using your own or a donor's immune cells to fight certain T-cell cancers that haven't responded to standard therapies. It may help people who have few other options left.
Beijing, Beijing MunicipalityAges 1–70 - NCT07070596Recruiting
Studying celiac disease and related gut conditions
This study collects information from people being checked for celiac disease to better understand the condition and improve diagnosis and treatment.
Terrassa, BarcelonaAges Any age - NCT07071051Recruiting
Study of calaspargase pegol on blood clotting in pediatric leukemia
This study looks at how a chemotherapy drug called calaspargase pegol affects blood clotting in children and young adults with leukemia. It will help doctors understand if changes in clotting are common and safe.
Rochester, MinnesotaAges 2–22 - NCT07071935RecruitingPhase 2
Early ventilation study for newly diagnosed ALS
This trial tests whether starting non-invasive ventilation (breathing support) early in ALS helps people breathe easier and live better. If you've been diagnosed with ALS in the last 6 months and haven't used a breathing machine before, you may qualify.
Hershey, PennsylvaniaAges 18 years+ - NCT07071948Recruiting
Study of VISOR for kidney stone treatment
This trial tests a new device called VISOR to help break up kidney stones using a flexible tube and laser. It's for adults aged 18–80 with stones between 1 and 3 cm who haven't had previous kidney surgery.
Hangzhou, ZhejiangAges 18–80 - NCT07072494RecruitingPhase 1/Phase 2
CD19 CAR-T cells as consolidation for B-cell ALL
This trial tests a single infusion of CD19 CAR-T cells as a consolidation treatment to keep leukemia in remission for patients who are not eligible for or decline a stem cell transplant. The goal is to see if this therapy can prevent relapse.
Guangzhou, GuangdongAges 14–80 - NCT07072611RecruitingEarly Phase 1
Safety study of SOF-SKN cream in healthy volunteers
This study tests a cream called SOF-SKN on healthy people to see if it's safe and how the body handles it. It is a first-in-human trial, so if you join, you'll help researchers learn about the cream before testing it in patients.
Melbourne, VictoriaAges 18–64 - NCT07073534RecruitingPhase 1/Phase 2
A study of two drugs for advanced solid tumors
This trial tests two drugs combined—SHR-1501 and adbelizumab—for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and effective.
Guangzhou, GuangdongAges 18–75 - NCT07073820RecruitingPhase 2
Longer-term study of PF-07868489 in pulmonary arterial hypertension
This study gives the investigational medicine PF-07868489 to people with pulmonary arterial hypertension who have already taken it in a previous Pfizer study. It checks if the medicine continues to be safe and helpful over a longer time.
Sacramento, CaliforniaAges 18 years+ - NCT07073963Recruiting
Online groups for sarcoidosis fatigue
This trial tests whether virtual group sessions can help reduce fatigue related to sarcoidosis. You'll join a supportive online group with others who have similar symptoms.
Cleveland, OhioAges 18 years+ - NCT07076472RecruitingEarly Phase 1
Sound and drug therapy for recurrent glioblastoma
This trial tests a new approach that combines a drug (SONALA-001 or 5-ALA) with focused ultrasound to treat glioblastoma that has come back or is growing despite standard treatments. The drug makes tumor cells sensitive to sound waves, and the ultrasound waves are directed at the tumor using MRI guidance. This may help damage cancer cells while sparing healthy brain tissue.
Rochester, MinnesotaAges 18 years+ - NCT07077122Recruiting
Comparing five gum disease treatments
This trial tests five different non-surgical gum treatments to see how they affect overall health. It may be a good fit for people with advanced gum disease who do not smoke heavily or take certain medications.
AthensAges Any age - NCT07077538Recruiting
Amino acid dialysis fluid for diabetic patients on PD
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
Gaozhou, GuangdongAges 18–75 - NCT07077616RecruitingEarly Phase 1
Personalized vaccine for recurrent glioma
This trial tests a personalized vaccine created by AI to target your specific brain tumor. It is for people with a glioma that came back after standard treatments like surgery, radiation, or chemotherapy, and whose tumor has enough genetic mutations to make the vaccine.
ThessalonikiAges 18 years+ - NCT07077772Recruiting
Guiding fluid removal after heart surgery
This trial tests a method to guide how much fluid is removed after heart surgery using a urine salt test, to see if it helps patients recover better. If you are having planned heart surgery with a heart-lung machine, you may be able to join.
AmiensAges 18 years+ - NCT07078877Recruiting
Laser therapy for knee osteoarthritis: a new option?
This study tests whether low-level laser therapy (a painless, non-surgical treatment using light) can reduce knee pain and improve knee function, cartilage health, and muscle strength in people with moderate knee osteoarthritis. It may be an option if you haven't had recent knee injections or physical therapy.
Ankara, YENIMAHALLEAges 50 years+ - NCT07078929RecruitingPhase 1
CAR T-cell therapy for children with relapsed or refractory ALL
This trial tests a new type of immune therapy called CAR T-cells (engineered to find and attack a protein called CD19 on leukemia cells) for children whose acute lymphoblastic leukemia has come back or hasn't responded to usual treatments. The goal is to see if these special cells can safely help control the disease.
Bangkok, BangkoknoiAges 1–18
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.